The lab study found a strong immune response to the U.K. and South African variants, with a ‘robust, but lower’ response to the South African variant.
Lab Study Suggests Pfizer/BioNTech Vaccine Effective Against Variants After Second Dose
The lab study found a strong immune response to the U.K. and South African variants, with a ‘robust, but lower’ response to the South African variant.